Patent 12496077

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Active provider: Google · gemini-2.5-flash

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

✓ Generated

Inventors

  • Kevin Swift (Employer: Angiodynamics Inc at time of filing)
  • Seth Cote (Employer: Angiodynamics Inc at time of filing)
  • Mark Girard (Employer: Angiodynamics Inc at time of filing)

All inventors were employed by the original assignee, Angiodynamics Inc, at the time of filing.

Original assignee

The original assignee is Angiodynamics Inc. Angiodynamics Inc. is a medical technology company that designs, manufactures, and sells a variety of medical devices for use in vascular access, peripheral vascular disease, and oncology. Their primary line of business is the development and commercialization of devices used in minimally invasive medical procedures. The company is currently operating.

Assignment timeline

A search of the USPTO Assignment Center for patent number 12496077 revealed no recorded assignments for this patent after its issuance. Therefore, the original assignee, Angiodynamics Inc, remains the current owner of record.

Timeline diagram

timeline
    title Ownership of US 12496077
    2015 : Priority date (Oct 16)
    2025 : Filed by Angiodynamics Inc (Jun 30)
    2025 : Issued to Angiodynamics Inc (Dec 16)

NPE / troll-pattern signals

  1. Shell-entity transfer — not present. There are no recorded transfers of this patent.
  2. Known asserter in the chain — not present. The sole recorded owner is Angiodynamics Inc, which is an operating company.
  3. Repeat correspondent across the chain — not present. No assignment chain exists for this patent.
  4. Cascading transfers — not present. No assignments have been recorded.
  5. Pre-litigation transfer — not present. No assignments have been recorded, and no litigation has been identified.
  6. Bankruptcy fire-sale — not present. Angiodynamics Inc is an operating public company.
  7. Privateering — not present. No evidence of privateering has been found.
  8. Defensive aggregator (anti-NPE) — not present. The patent remains with the original operating company.

Verdict

Insufficient data. As there are no recorded assignments for US 12496077 after its issuance, it remains with the original operating company, Angiodynamics Inc. Therefore, there are no NPE or patent-troll patterns to analyze. The absence of assignments prevents a conclusive determination of NPE activity.

Generated 5/30/2026, 6:47:18 PM